Tag: AST-004

Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug

Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....